ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1,4,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1,5,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
2,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
2,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
3,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
3,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
4,1,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
4,2,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
4,3,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
5,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
5,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
6,1,Lip dry,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
7,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
7,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
7,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
7,4,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
7,5,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
7,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
7,7,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
8,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
8,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
9,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
9,2,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
9,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
10,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
10,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
11,2,Headache,Headaches NEC,Headaches,Nerv,N
11,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
11,4,Social avoidant behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
11,5,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
12,1,Petit mal epilepsy,Absence seizures,Seizures (incl subtypes),Nerv,N
12,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
13,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
13,2,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
13,3,Social avoidant behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
14,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
14,2,Petit mal epilepsy,Absence seizures,Seizures (incl subtypes),Nerv,N
14,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
15,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
15,2,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
15,3,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
16,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
16,2,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
16,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
17,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
18,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
18,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
19,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
20,1,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
21,1,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
22,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
22,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
22,3,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
23,1,General symptom,General signs and symptoms NEC,General system disorders NEC,Genrl,N
23,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
24,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
25,1,Headache,Headaches NEC,Headaches,Nerv,N
25,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
26,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
26,2,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
26,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
27,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
27,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
27,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
27,4,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
28,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
28,2,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
29,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
29,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
29,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
29,4,Dysphoria,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
29,5,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
29,6,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
29,7,Tic,Tic disorders,Changes in physical activity,Psych,N
30,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
30,2,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
31,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
31,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
31,3,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
31,4,Screaming,General signs and symptoms NEC,General system disorders NEC,Genrl,N
31,5,Trance,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
32,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
33,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
34,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
34,2,Headache,Headaches NEC,Headaches,Nerv,N
34,3,Sedation,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
34,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
35,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
35,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
35,3,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
35,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
36,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
36,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
36,3,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
36,4,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
37,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
37,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
37,3,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
37,4,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
37,5,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
37,6,Tic,Tic disorders,Changes in physical activity,Psych,N
38,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
38,2,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
38,3,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
38,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
38,5,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
38,6,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
39,1,Eyelid irritation,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
39,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
39,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
39,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
40,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
41,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
42,1,Autism spectrum disorder,Pervasive developmental disorders NEC,Developmental disorders NEC,Psych,N
42,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
42,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
42,4,Intentional self-injury,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
43,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
43,2,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
43,3,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
44,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
44,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
45,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
45,2,Head banging,Stereotypies and automatisms,Changes in physical activity,Psych,N
46,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
46,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
46,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
46,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
46,5,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
47,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
47,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
48,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
49,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
50,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
50,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
50,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
50,4,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
51,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
51,2,Change in sustained attention,Cognitive and attention disorders and disturbances NEC,Cognitive and attention disorders and disturbances,Psych,N
51,3,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
51,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
51,5,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
51,6,Oromandibular dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
51,7,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
51,8,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
51,9,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
52,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
52,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
53,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
53,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
53,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
53,4,Headache,Headaches NEC,Headaches,Nerv,N
53,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
53,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
53,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
54,1,Dysphemia,Speech articulation and rhythm disturbances,Communication disorders and disturbances,Psych,N
54,2,Tic,Tic disorders,Changes in physical activity,Psych,N
55,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
56,1,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
57,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
58,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
58,2,Headache,Headaches NEC,Headaches,Nerv,N
58,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
58,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
58,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
59,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
59,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
59,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
60,1,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
60,2,Penis disorder,Penile disorders NEC (excl erection and ejaculation),Penile and scrotal disorders (excl infections and inflammations),Repro,N
60,3,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
61,1,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
62,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
62,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
63,1,Hyperventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
63,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
64,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
64,2,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
65,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
65,2,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
65,3,Morbid thoughts,Thinking disturbances,Disturbances in thinking and perception,Psych,N
65,4,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
65,5,Self-injurious ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
66,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
67,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
68,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
68,2,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
68,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
68,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
69,1,Urinary hesitation,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
69,2,Urine flow decreased,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
70,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
71,1,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
72,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
72,2,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
73,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
73,2,Intentional self-injury,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
74,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
74,2,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
75,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
76,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
76,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
77,1,Asocial behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
77,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
78,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
79,1,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
79,2,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
79,3,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
80,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
80,2,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
80,3,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
81,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
81,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
81,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
81,4,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
81,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
81,6,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
81,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
81,8,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
81,9,Headache,Headaches NEC,Headaches,Nerv,N
81,10,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
81,11,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
81,12,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
81,13,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
82,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
83,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
84,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
84,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
85,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
86,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
86,2,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
86,3,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
86,4,Hyperaldosteronism,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
87,1,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
88,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
88,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
88,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
89,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
89,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
89,3,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
89,4,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
89,5,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
89,6,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
89,7,Oromandibular dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
89,8,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
90,1,Livedo reticularis,Skin vasomotor conditions,Skin vascular abnormalities,Skin,N
90,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
91,1,Vasoconstriction,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
92,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
92,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
92,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
92,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
92,5,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
93,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
93,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
93,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
93,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
94,1,Anhedonia,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
94,2,Dysphoria,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
94,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
95,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
95,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
95,3,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
96,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
96,2,Dysphoria,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
96,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
97,1,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
98,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
99,1,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
100,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
100,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
100,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
101,1,Postural orthostatic tachycardia syndrome,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
101,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
102,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
102,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
102,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
102,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
102,5,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
103,1,Foaming at mouth,General signs and symptoms NEC,General system disorders NEC,Genrl,N
103,2,Mastication disorder,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
104,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
104,2,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
105,1,Affect lability,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
105,2,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
105,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
105,4,Foaming at mouth,General signs and symptoms NEC,General system disorders NEC,Genrl,N
105,5,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
105,6,Tic,Tic disorders,Changes in physical activity,Psych,N
105,7,Tongue spasm,Tongue signs and symptoms,Tongue conditions,Gastr,N
106,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
106,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
106,3,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
106,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
107,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
107,2,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
108,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
108,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
108,3,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
108,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
109,1,Headache,Headaches NEC,Headaches,Nerv,N
109,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
110,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
110,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
110,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
111,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
112,1,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
112,2,Urine output increased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
113,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
114,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
115,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
116,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
116,2,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
116,3,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
117,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
118,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
118,2,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
118,3,Muscle contracture,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
118,4,Muscle spasticity,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
118,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
119,1,Galactorrhoea,Lactation disorders,Breast disorders,Repro,N
120,1,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
120,2,Psychotic symptom,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
121,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
121,2,Angina pectoris,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
121,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
121,4,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
121,5,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
121,6,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
121,7,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
121,8,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
121,9,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
121,10,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
121,11,Headache,Headaches NEC,Headaches,Nerv,N
121,12,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
121,13,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
121,14,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
121,15,Logorrhoea,Speech and language usage disturbances,Communication disorders and disturbances,Psych,N
121,16,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
121,17,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
121,18,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
121,19,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
122,1,Tic,Tic disorders,Changes in physical activity,Psych,N
123,1,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
124,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
124,2,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
124,3,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
125,1,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
125,2,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
125,3,Tic,Tic disorders,Changes in physical activity,Psych,N
126,1,Increased tendency to bruise,Bleeding tendencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
127,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
127,2,"Hallucinations, mixed",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
127,3,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
128,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
128,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
129,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
130,1,Headache,Headaches NEC,Headaches,Nerv,N
131,1,Colitis ischaemic,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,Y
132,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
133,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
133,2,Oral mucosal blistering,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
134,1,Inhibitory drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
135,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
135,2,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
135,3,Opisthotonus,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
135,4,Oromandibular dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
135,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
136,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
136,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
136,3,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
137,1,Muscle tightness,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
137,2,Myalgia,Muscle pains,Muscle disorders,Musc,N
138,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
139,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
139,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
139,3,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
139,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
139,5,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
140,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
141,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
142,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
142,2,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
143,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
143,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
143,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
143,4,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
143,5,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
143,6,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
144,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
145,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
145,2,Vaginal odour,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
146,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
146,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
147,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
147,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
147,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
147,4,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
147,5,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
147,6,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
148,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
148,2,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
149,1,Blood pressure diastolic increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
150,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
151,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
152,1,Abnormal dreams,Parasomnias,Sleep disorders and disturbances,Psych,N
152,2,Diabetes mellitus,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
152,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
152,4,Language disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
152,5,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
152,6,Overweight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
152,7,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
152,8,Sexual dysfunction,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
153,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
153,2,Enuresis,Psychiatric elimination disorders,Psychiatric disorders NEC,Psych,N
153,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
153,4,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
154,1,Alcohol detoxification,Drug withdrawal therapies,Therapeutic procedures and supportive care NEC,Surg,N
154,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
155,1,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
156,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
156,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
156,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
156,4,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
156,5,Feeling jittery,Feelings and sensations NEC,General system disorders NEC,Genrl,N
156,6,Suicidal behaviour,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
157,1,Alopecia areata,Alopecias,Skin appendage conditions,Skin,N
158,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
159,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
159,2,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
159,3,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
159,4,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
160,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
161,1,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
161,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
161,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
161,4,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
162,1,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
163,1,Chloasma,Hyperpigmentation disorders,Pigmentation disorders,Skin,N
164,1,Acute psychosis,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
165,1,Intentional self-injury,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
166,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
166,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
167,1,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
168,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
168,2,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
169,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
169,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
169,3,Food interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
169,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
170,1,Eructation,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
171,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
171,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
171,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
171,4,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
171,5,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
171,6,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
172,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
172,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
172,3,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
172,4,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
172,5,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
172,6,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
172,7,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
172,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
173,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
174,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
175,1,Disinhibition,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
175,2,Disturbance in sexual arousal,Sexual arousal disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
176,1,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
177,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
177,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
178,1,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
179,1,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
180,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
181,1,Logorrhoea,Speech and language usage disturbances,Communication disorders and disturbances,Psych,N
182,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
182,2,Homicidal ideation,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
183,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
183,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
183,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
183,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
183,5,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
183,6,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
183,7,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
183,8,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
184,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
184,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
184,3,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
184,4,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
185,1,Behaviour disorder,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
185,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
185,3,Obsessive-compulsive disorder,Obsessive-compulsive disorders and symptoms,Anxiety disorders and symptoms,Psych,N
185,4,Obsessive-compulsive symptom,Obsessive-compulsive disorders and symptoms,Anxiety disorders and symptoms,Psych,N
185,5,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
185,6,Tic,Tic disorders,Changes in physical activity,Psych,N
186,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
186,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
186,3,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
187,1,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
187,2,Temperature intolerance,Feelings and sensations NEC,General system disorders NEC,Genrl,N
188,1,Menstrual disorder,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
189,1,Cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
189,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
190,1,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
190,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
190,3,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
191,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
191,2,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
191,3,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
191,4,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
191,5,Staring,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
191,6,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
192,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
193,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
193,2,Thyroid cancer,Thyroid neoplasms malignant,Endocrine neoplasms malignant and unspecified,Neopl,N
194,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
194,2,Dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
194,3,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
194,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
194,5,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
194,6,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
195,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
195,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
195,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
195,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
195,5,Schizophreniform disorder,Schizoaffective and schizophreniform disorders,Schizophrenia and other psychotic disorders,Psych,N
196,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
197,1,Bronchiectasis,Bronchial conditions NEC,Bronchial disorders (excl neoplasms),Resp,N
197,2,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
197,3,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
197,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
197,5,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
197,6,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
197,7,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
197,8,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
197,9,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
197,10,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
197,11,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
197,12,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
197,13,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
197,14,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
197,15,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
197,16,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
197,17,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
197,18,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
197,19,Steroid dependence,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
197,20,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
197,21,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
198,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
198,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
198,3,Penile pain,Penile disorders NEC (excl erection and ejaculation),Penile and scrotal disorders (excl infections and inflammations),Repro,N
198,4,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
198,5,Poor peripheral circulation,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
199,1,Ejaculation disorder,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
199,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
199,3,Prostatomegaly,"Prostatic signs, symptoms and disorders NEC",Prostatic disorders (excl infections and inflammations),Repro,N
200,1,Logorrhoea,Speech and language usage disturbances,Communication disorders and disturbances,Psych,N
200,2,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
201,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
201,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
201,3,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
201,4,Headache,Headaches NEC,Headaches,Nerv,N
202,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
203,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
204,1,Bradycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
204,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
204,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
205,1,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
206,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
207,1,Bruxism,Stereotypies and automatisms,Changes in physical activity,Psych,N
207,2,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
208,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
208,2,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
209,1,Basophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
209,2,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
209,3,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
209,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
209,5,Mean cell haemoglobin concentration decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
209,6,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
209,7,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
209,8,Red cell distribution width increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
209,9,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
209,10,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
209,11,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
210,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
210,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
210,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
210,4,Headache,Headaches NEC,Headaches,Nerv,N
210,5,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
210,6,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
210,7,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
210,8,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
210,9,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
210,10,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
210,11,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
210,12,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
210,13,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
210,14,Tachypnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
210,15,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
210,16,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
211,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
212,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
213,1,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
214,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
215,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
216,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
216,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
217,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
217,2,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
217,3,Partial seizures,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
217,4,Product formulation issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
217,5,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
217,6,Therapeutic product effect variable,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
218,1,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
219,1,Clonus,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
220,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
220,2,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
220,3,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
220,4,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
220,5,Self-injurious ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
221,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
221,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
221,3,Intentional self-injury,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
221,4,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
221,5,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
221,6,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
222,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
223,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
223,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
223,3,Septic rash,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
223,4,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
224,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
225,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
226,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
227,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
228,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
229,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
229,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
230,1,Pancreatitis,Acute and chronic pancreatitis,Exocrine pancreas conditions,Gastr,N
231,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
231,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
231,3,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
232,1,Tardive dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
233,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
233,2,Bile output abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
233,3,Headache,Headaches NEC,Headaches,Nerv,N
233,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
234,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
234,2,Lip ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
234,3,Pustule,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
235,1,Acne cystic,Acnes,Skin appendage conditions,Skin,N
235,2,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
236,1,Oral mucosal eruption,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
236,2,Oral pruritus,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
237,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
237,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
237,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
237,4,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
237,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
237,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
238,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
238,2,Trismus,Muscle tone abnormalities,Muscle disorders,Musc,N
239,1,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
240,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
241,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
241,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
241,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
241,4,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
241,5,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
242,1,Gastric haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
243,1,Bacterial infection,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
243,2,Delirium,Deliria,Deliria (incl confusion),Psych,N
243,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
243,4,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
243,5,Paranoia,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
243,6,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
244,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
245,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
245,2,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
245,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
245,4,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
245,5,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
245,6,"Hallucination, visual",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
245,7,Headache,Headaches NEC,Headaches,Nerv,N
245,8,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
245,9,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
245,10,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
245,11,Patient dissatisfaction with treatment,Social issues NEC,Lifestyle issues,SocCi,N
245,12,Physical product label issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
245,13,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
245,14,Product colour issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
245,15,Product label issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
245,16,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
245,17,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
245,18,Refusal of treatment by patient,Social issues NEC,Lifestyle issues,SocCi,N
245,19,Suspected counterfeit product,"Counterfeit, falsified and substandard products","Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
245,20,Therapeutic product effect increased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
245,21,Therapeutic product effect variable,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
245,22,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
246,1,Head injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
246,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
246,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
247,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
247,2,Blood glucose fluctuation,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
247,3,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
247,4,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
247,5,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
248,1,Epiglottitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
248,2,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
248,3,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
248,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
249,1,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
249,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
250,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
250,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
250,3,Hypophosphataemia,Phosphorus metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
251,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
251,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
252,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
252,2,Urinary hesitation,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
253,1,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
253,2,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
254,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
254,2,Excessive eye blinking,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
254,3,Oculogyric crisis,Ocular nerve and muscle disorders,Ocular neuromuscular disorders,Eye,N
255,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
255,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
255,3,Tachyphrenia,Thinking disturbances,Disturbances in thinking and perception,Psych,N
256,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
257,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
257,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
257,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
257,4,Logorrhoea,Speech and language usage disturbances,Communication disorders and disturbances,Psych,N
258,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
258,2,Pigmentation disorder,Pigmentation changes NEC,Pigmentation disorders,Skin,N
259,1,Acne,Acnes,Skin appendage conditions,Skin,N
259,2,Appetite disorder,Appetite disorders,Appetite and general nutritional disorders,Metab,N
259,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
259,4,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
259,5,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
259,6,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
260,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
260,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
260,3,Hyperacusis,Hyperacusia,Hearing disorders,Ear,N
260,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
261,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
261,2,Hyperacusis,Hyperacusia,Hearing disorders,Ear,N
261,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
261,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
262,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
262,2,Headache,Headaches NEC,Headaches,Nerv,N
262,3,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
262,4,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
263,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
263,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
263,3,Therapeutic response shortened,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
264,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
264,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
265,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
265,2,Therapeutic response shortened,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
266,1,Bruxism,Stereotypies and automatisms,Changes in physical activity,Psych,N
266,2,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
267,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
267,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
268,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
268,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
268,3,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
269,1,Sexual dysfunction,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
270,1,Sadism,Paraphilias and paraphilic disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
270,2,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
271,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
271,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
272,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
273,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
273,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
273,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
273,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
273,5,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
273,6,Headache,Headaches NEC,Headaches,Nerv,N
273,7,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
273,8,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
273,9,Lip dry,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
273,10,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
273,11,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
273,12,Neuromyopathy,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
273,13,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
273,14,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
273,15,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
274,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
274,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
274,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
274,4,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
275,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
275,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
275,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
275,4,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
275,5,Sleep deficit,Sleep disturbances NEC,Sleep disturbances (incl subtypes),Nerv,N
276,1,Premenstrual syndrome,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
277,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
277,2,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
278,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
278,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
279,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
279,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
280,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
280,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
281,1,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
281,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
282,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
282,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
283,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
283,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
283,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
284,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
284,2,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
285,1,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
286,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
286,2,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
287,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
288,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
288,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
288,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
288,4,Drug effect less than expected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
288,5,Hunger,Feelings and sensations NEC,General system disorders NEC,Genrl,N
288,6,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
288,7,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
289,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
289,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
290,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
291,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
291,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
292,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
292,2,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
293,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
294,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
295,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
295,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
295,3,Headache,Headaches NEC,Headaches,Nerv,N
296,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
296,2,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
296,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
297,1,Affective disorder,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
297,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
298,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
299,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
299,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
300,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
300,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
301,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
301,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
301,3,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
302,1,Underweight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
303,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
303,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
304,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
304,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
305,1,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
306,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
306,2,Therapeutic response shortened,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
307,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
308,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
308,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
309,1,Tic,Tic disorders,Changes in physical activity,Psych,N
310,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
311,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
312,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
312,2,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
313,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
313,2,Defiant behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
314,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
314,2,Patient dissatisfaction with treatment,Social issues NEC,Lifestyle issues,SocCi,N
315,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
315,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
315,3,Growth retardation,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
315,4,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
315,5,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
315,6,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
316,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
316,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
317,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
317,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
318,1,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
318,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
319,1,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
320,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
320,2,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
321,1,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
322,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
322,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
323,1,Hyperphagia,Appetite disorders,Appetite and general nutritional disorders,Metab,N
323,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
324,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
324,2,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
325,1,Behaviour disorder,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
325,2,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
326,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
327,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
327,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
328,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
328,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
329,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
329,2,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
330,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
330,2,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
330,3,Feeling of despair,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
330,4,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
330,5,Negative thoughts,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
330,6,Substance-induced psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
331,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
332,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
333,1,Delusion,Delusional symptoms,Disturbances in thinking and perception,Psych,N
333,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
334,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
334,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
335,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
336,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
336,2,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
337,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
338,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
339,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
339,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
340,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
341,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
342,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
342,2,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
343,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
343,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
343,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
344,1,White blood cell count,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
345,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
345,2,Tongue coated,Tongue signs and symptoms,Tongue conditions,Gastr,N
346,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
346,2,Tongue coated,Tongue signs and symptoms,Tongue conditions,Gastr,N
347,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
347,2,Tongue disorder,Tongue disorders,Tongue conditions,Gastr,N
348,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
348,2,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
349,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
349,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
349,3,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
350,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
350,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
350,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
350,4,Dermatillomania,Obsessive-compulsive disorders and symptoms,Anxiety disorders and symptoms,Psych,N
350,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
350,6,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
350,7,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
350,8,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
350,9,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
350,10,Mydriasis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
350,11,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
350,12,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
351,1,Affect lability,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
351,2,Blood pressure systolic decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
351,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
351,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
351,5,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
351,6,Social avoidant behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
351,7,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
352,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
352,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
352,3,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
352,4,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
352,5,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
352,6,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
352,7,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
353,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
353,2,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
353,3,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
354,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
354,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
354,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
354,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
354,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
354,6,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
354,7,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
355,1,Behaviour disorder,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
355,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
355,3,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
355,4,Rebound effect,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
356,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
356,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
356,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
356,4,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
357,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
357,2,Coma,Coma states,Neurological disorders NEC,Nerv,N
358,1,Sexual dysfunction,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
359,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
359,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
359,3,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
359,4,Homicidal ideation,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
359,5,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
360,1,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
360,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
361,1,Libido increased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
361,2,Sexual dysfunction,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
362,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
363,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
364,1,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
365,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
365,2,Gastric pH increased,Gastrointestinal function diagnostic procedures,Gastrointestinal investigations,Inv,N
365,3,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
365,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
365,5,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
366,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
367,1,Menstrual disorder,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
367,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
368,1,Cystitis,Urinary tract infections,Infections - pathogen unspecified,Infec,N
368,2,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
369,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
369,2,Frustration tolerance decreased,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
369,3,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
370,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
371,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
371,2,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
372,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
372,2,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
373,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
373,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
373,3,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
373,4,Hypomania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
373,5,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
374,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
374,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
374,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
374,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
374,5,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
375,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
375,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
376,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
376,2,Gestational diabetes,Pregnancy complicated by maternal disorders,Maternal complications of pregnancy,Preg,N
377,1,Gestational diabetes,Pregnancy complicated by maternal disorders,Maternal complications of pregnancy,Preg,N
377,2,Maternal condition affecting foetus,Foetal conditions due to maternal conditions,Foetal complications,Preg,N
378,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
378,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
378,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
379,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
379,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
380,1,Dysphemia,Speech articulation and rhythm disturbances,Communication disorders and disturbances,Psych,N
381,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
381,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
381,3,Headache,Headaches NEC,Headaches,Nerv,N
381,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
381,5,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
382,1,Menstruation delayed,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
383,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
383,2,Cognitive disorder,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
383,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
383,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
383,5,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
383,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
383,7,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
383,8,Hypopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
383,9,Inflammation,Inflammations,General system disorders NEC,Genrl,N
383,10,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
383,11,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
383,12,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
384,1,Petit mal epilepsy,Absence seizures,Seizures (incl subtypes),Nerv,N
385,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
386,1,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
387,1,Affect lability,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
388,1,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
388,2,Therapeutic product effect variable,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
388,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
389,1,Appetite disorder,Appetite disorders,Appetite and general nutritional disorders,Metab,N
389,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
389,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
390,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
390,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
391,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
392,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
392,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
392,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
393,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
394,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
394,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
394,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
394,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
395,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
395,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
395,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
395,4,Headache,Headaches NEC,Headaches,Nerv,N
395,5,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
395,6,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
395,7,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
395,8,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
396,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
397,1,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
397,2,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
397,3,Psychotic symptom,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
397,4,Substance use,Social issues NEC,Lifestyle issues,SocCi,N
398,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
398,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
398,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
398,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
398,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
399,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
400,1,Change in sustained attention,Cognitive and attention disorders and disturbances NEC,Cognitive and attention disorders and disturbances,Psych,N
400,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
400,3,Muscle tightness,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
401,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
402,1,Change in sustained attention,Cognitive and attention disorders and disturbances NEC,Cognitive and attention disorders and disturbances,Psych,N
402,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
402,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
402,4,Trismus,Muscle tone abnormalities,Muscle disorders,Musc,N
403,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
403,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
403,3,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
403,4,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
403,5,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
403,6,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
403,7,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
403,8,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
403,9,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
403,10,Hunger,Feelings and sensations NEC,General system disorders NEC,Genrl,N
403,11,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
403,12,Muscle tightness,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
403,13,Myalgia,Muscle pains,Muscle disorders,Musc,N
403,14,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
403,15,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
403,16,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
404,1,Product preparation issue,Product preparation errors and issues,Medication errors and other product use errors and issues,Inj&P,N
404,2,Selective eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
405,1,Tic,Tic disorders,Changes in physical activity,Psych,N
405,2,Tourette's disorder,Neurological disorders congenital NEC,Neurological disorders congenital,Cong,N
406,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
406,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
406,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
406,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
406,5,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
406,6,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
406,7,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
407,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
407,2,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
407,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
407,4,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
408,1,Hypersexuality,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
408,2,Libido increased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
409,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
410,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
411,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
412,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
412,2,Major depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
412,3,Social problem,Social issues NEC,Lifestyle issues,SocCi,N
412,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
413,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
413,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
414,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
415,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
416,1,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
417,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
418,1,Acne cystic,Acnes,Skin appendage conditions,Skin,N
419,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
419,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
420,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
421,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
421,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
421,3,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
421,4,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
421,5,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
421,6,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
422,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
422,2,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
422,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
422,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
423,1,Loss of libido,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
424,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
424,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
425,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
425,2,Fear,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
425,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
425,4,Headache,Headaches NEC,Headaches,Nerv,N
425,5,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
426,1,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
426,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
427,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
427,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
427,3,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
428,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
428,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
428,3,Bruxism,Stereotypies and automatisms,Changes in physical activity,Psych,N
428,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
428,5,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
428,6,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
428,7,Headache,Headaches NEC,Headaches,Nerv,N
428,8,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
428,9,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
429,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
430,1,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
431,1,Drug screen positive,Toxicology laboratory analyses,Toxicology and therapeutic drug monitoring,Inv,N
432,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
432,2,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
433,1,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
434,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
435,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
435,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
436,1,Urinary hesitation,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
437,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
437,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
437,3,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
437,4,Nail pitting,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
438,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
439,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
440,1,Autophobia,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
440,2,Dysphoria,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
440,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
440,4,Sleep deficit,Sleep disturbances NEC,Sleep disturbances (incl subtypes),Nerv,N
440,5,Sleep deficit,Sleep disturbances NEC,Sleep disturbances (incl subtypes),Nerv,N
441,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
442,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
442,2,Gluten sensitivity,Food malabsorption and intolerance syndromes (excl sugar intolerance),Food intolerance syndromes,Metab,N
443,1,Blood pressure abnormal,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
443,2,Heart rate abnormal,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
443,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
444,1,Blood pressure diastolic increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
444,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
444,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
444,4,Headache,Headaches NEC,Headaches,Nerv,N
444,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
444,6,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
445,1,Electrocardiogram PR shortened,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
446,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
446,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
446,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
446,4,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
446,5,Gastrointestinal motility disorder,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
446,6,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
446,7,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
446,8,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
446,9,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
446,10,Migraine,Migraine headaches,Headaches,Nerv,N
446,11,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
446,12,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
446,13,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
446,14,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
446,15,Myalgia,Muscle pains,Muscle disorders,Musc,N
446,16,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
446,17,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
446,18,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
447,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
447,2,Bladder disorder,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
447,3,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
448,1,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
448,2,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
449,1,Meningitis viral,Viral infections NEC,Viral infectious disorders,Infec,N
449,2,Photosensitivity reaction,Photosensitivity and photodermatosis conditions,Epidermal and dermal conditions,Skin,N
450,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
451,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
451,2,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
451,3,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
451,4,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
451,5,Drug effect less than expected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
451,6,Food craving,Appetite disorders,Appetite and general nutritional disorders,Metab,N
451,7,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
451,8,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
451,9,Myalgia,Muscle pains,Muscle disorders,Musc,N
452,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
453,1,Mania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
454,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
455,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
455,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
456,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
456,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
456,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
456,4,Hyponatraemic seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
456,5,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
456,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
456,7,Polydipsia,Fluid intake increased,Electrolyte and fluid balance conditions,Metab,N
456,8,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
456,9,Sexual dysfunction,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
456,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
457,1,Circumstance or information capable of leading to medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
457,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
457,3,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
457,4,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
458,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
458,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
458,3,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
458,4,Fear of death,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
458,5,Head discomfort,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
458,6,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
458,7,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
458,8,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
458,9,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
458,10,Physical assault,Criminal activity,Legal issues,SocCi,N
458,11,Poisoning,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
458,12,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
458,13,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
458,14,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
458,15,Sleep apnoea syndrome,Breathing abnormalities,Respiratory disorders NEC,Resp,N
458,16,Suspected counterfeit product,"Counterfeit, falsified and substandard products","Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
458,17,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
459,1,Acne,Acnes,Skin appendage conditions,Skin,N
459,2,Acne cystic,Acnes,Skin appendage conditions,Skin,N
459,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
460,1,Disturbance in sexual arousal,Sexual arousal disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
461,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
462,1,Acne,Acnes,Skin appendage conditions,Skin,N
462,2,Oral candidiasis,Candida infections,Fungal infectious disorders,Infec,N
463,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
463,2,Poor peripheral circulation,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
464,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
464,2,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
465,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
466,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
466,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
467,1,Conversion disorder,Somatic symptom disorders,Somatic symptom and related disorders,Psych,N
467,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
467,3,Dysphemia,Speech articulation and rhythm disturbances,Communication disorders and disturbances,Psych,N
467,4,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
467,5,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
467,6,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
467,7,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
467,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
468,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
469,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
470,1,Sexual dysfunction,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
471,1,Sexual dysfunction,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
472,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
472,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
472,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
473,1,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
473,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
473,3,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
474,1,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
474,2,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
475,1,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
476,1,Hypermetabolism,Metabolic disorders NEC,Metabolism disorders NEC,Metab,N
477,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
477,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
477,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
477,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
478,1,Alice in wonderland syndrome,Delusional disorders,Schizophrenia and other psychotic disorders,Psych,N
478,2,Illusion,Perception disturbances NEC,Disturbances in thinking and perception,Psych,N
479,1,Depersonalisation/derealisation disorder,Dissociative states,Dissociative disorders,Psych,N
479,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
479,3,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
479,4,Visual snow syndrome,Visual disorders NEC,Vision disorders,Eye,N
480,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
480,2,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
481,1,Laryngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
482,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
483,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
484,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
484,2,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
484,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
485,1,Nail discolouration,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
485,2,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
486,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
486,2,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
487,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
488,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
488,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
488,3,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
488,4,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
488,5,Seasonal allergy,Atopic disorders,Allergic conditions,Immun,N
488,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
489,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
489,2,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
490,1,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
491,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
491,2,Product lot number issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
492,1,Headache,Headaches NEC,Headaches,Nerv,N
493,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
493,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
493,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
493,4,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
493,5,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
493,6,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
494,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
494,2,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
495,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
496,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
496,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
496,3,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
496,4,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
496,5,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
497,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
497,2,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
497,3,Inappropriate schedule of product discontinuation,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
497,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
498,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
499,1,Amphetamines positive,Toxicology laboratory analyses,Toxicology and therapeutic drug monitoring,Inv,N
499,2,Drug level above therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
499,3,Morning sickness,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
499,4,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
500,1,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
501,1,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
502,1,Personality change,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
503,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
503,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
503,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
504,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
504,2,Hyperaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
504,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
504,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
505,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
505,2,Drug screen positive,Toxicology laboratory analyses,Toxicology and therapeutic drug monitoring,Inv,N
505,3,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
505,4,Migraine,Migraine headaches,Headaches,Nerv,N
506,1,Acne,Acnes,Skin appendage conditions,Skin,N
506,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
507,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
508,1,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
508,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
508,3,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
508,4,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
509,1,Therapeutic response shortened,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
509,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
510,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
510,2,Sensory overload,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
511,1,Nocturia,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
511,2,Polyuria,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
512,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
513,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
514,1,Therapy interrupted,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
515,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
515,2,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
515,3,Therapeutic product effect delayed,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
515,4,Therapeutic product effect variable,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
516,1,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
516,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
516,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
516,4,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
516,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
516,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
517,1,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
517,2,Blood iron decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
517,3,Distractibility,Cognitive and attention disorders and disturbances NEC,Cognitive and attention disorders and disturbances,Psych,N
517,4,Drug effect less than expected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
517,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
517,6,Vitamin D decreased,Vitamin analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
518,1,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
519,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
519,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
520,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
520,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
521,1,Micturition urgency,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
521,2,Sexual dysfunction,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
522,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
522,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
522,3,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
522,4,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
522,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
522,6,Therapeutic product effect variable,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
522,7,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
523,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
523,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
523,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
523,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
523,5,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
523,6,Premature ageing,General signs and symptoms NEC,General system disorders NEC,Genrl,N
523,7,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
524,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
525,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
526,1,Acne,Acnes,Skin appendage conditions,Skin,N
527,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
528,1,Headache,Headaches NEC,Headaches,Nerv,N
528,2,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
528,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
528,4,Myalgia,Muscle pains,Muscle disorders,Musc,N
528,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
529,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
530,1,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
531,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
532,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
533,1,Groin pain,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
534,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
534,2,Impetigo,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
534,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
535,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
536,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
537,1,Headache,Headaches NEC,Headaches,Nerv,N
538,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
538,2,Dermatillomania,Obsessive-compulsive disorders and symptoms,Anxiety disorders and symptoms,Psych,N
538,3,Headache,Headaches NEC,Headaches,Nerv,N
538,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
539,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
540,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
541,1,Functional gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
542,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
542,2,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
543,1,Bruxism,Stereotypies and automatisms,Changes in physical activity,Psych,N
544,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
545,1,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
546,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
546,2,Social avoidant behaviour,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
547,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
548,1,Tic,Tic disorders,Changes in physical activity,Psych,N
549,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
549,2,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
549,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
549,4,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
550,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
550,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
550,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
551,1,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
551,2,Tension headache,Headaches NEC,Headaches,Nerv,N
552,1,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
553,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
553,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
553,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
554,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
555,1,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
556,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
557,1,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
558,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
559,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
559,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
560,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
560,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
561,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
562,1,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
563,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
563,2,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
563,3,Pregnancy,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
563,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
563,5,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
564,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
565,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
566,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
566,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
566,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
566,4,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
566,5,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
566,6,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
566,7,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
566,8,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
567,1,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
567,2,Product use complaint,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
568,1,"Hallucination, auditory",Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
568,2,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
569,1,Systemic lupus erythematosus rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
570,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
571,1,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
572,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
573,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
574,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
574,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
575,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
576,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
577,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
577,2,Headache,Headaches NEC,Headaches,Nerv,N
577,3,Heart rate abnormal,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
577,4,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
577,5,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
577,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
577,7,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
577,8,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
578,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
579,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
580,1,Vulvovaginal dryness,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
581,1,Acne,Acnes,Skin appendage conditions,Skin,N
582,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
582,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
582,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
583,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
583,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
583,3,Poor quality product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
583,4,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
583,5,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
583,6,Product taste abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
584,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
585,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
586,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
586,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
586,3,Feeling jittery,Feelings and sensations NEC,General system disorders NEC,Genrl,N
587,1,Bruxism,Stereotypies and automatisms,Changes in physical activity,Psych,N
588,1,Feeling jittery,Feelings and sensations NEC,General system disorders NEC,Genrl,N
588,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
588,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
588,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
589,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
589,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
589,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
590,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
590,2,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
591,1,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
591,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
591,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
591,4,Therapeutic product effect variable,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
592,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
592,2,Headache,Headaches NEC,Headaches,Nerv,N
592,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
592,4,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
592,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
592,6,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
592,7,Trismus,Muscle tone abnormalities,Muscle disorders,Musc,N
593,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
594,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
594,2,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
594,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
595,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
595,2,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
596,1,Drug effect less than expected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
596,2,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
596,3,Therapeutic response shortened,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
597,1,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
598,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
598,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
599,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
599,2,Asthenopia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
599,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
599,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
599,5,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
599,6,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
599,7,Therapeutic response shortened,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
600,1,Product preparation issue,Product preparation errors and issues,Medication errors and other product use errors and issues,Inj&P,N
600,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
600,3,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
601,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
601,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
602,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
602,2,Disturbance in sexual arousal,Sexual arousal disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
602,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
602,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
602,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
603,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
603,2,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
604,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
604,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
605,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
605,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
605,3,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
605,4,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
605,5,Nerve compression,Mononeuropathies,Peripheral neuropathies,Nerv,N
605,6,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
605,7,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
606,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
607,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
607,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
607,3,Product distribution issue,Product distribution and storage issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
607,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
607,5,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
608,1,Acne,Acnes,Skin appendage conditions,Skin,N
609,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
610,1,Vulvovaginal dryness,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
611,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
611,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
611,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
611,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
611,5,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
611,6,Tic,Tic disorders,Changes in physical activity,Psych,N
611,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
611,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
612,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
613,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
614,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
615,1,Hypomenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
616,1,Vitreous floaters,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
617,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
618,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
618,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
619,1,Dermatillomania,Obsessive-compulsive disorders and symptoms,Anxiety disorders and symptoms,Psych,N
620,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
620,2,Therapeutic response shortened,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
621,1,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
622,1,Migraine with aura,Migraine headaches,Headaches,Nerv,N
622,2,Therapeutic response shortened,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
623,1,Bruxism,Stereotypies and automatisms,Changes in physical activity,Psych,N
623,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
624,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
624,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
625,1,Dental operation,Dental and gingival therapeutic procedures,Head and neck therapeutic procedures,Surg,N
625,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
625,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
626,1,Migraine,Migraine headaches,Headaches,Nerv,N
626,2,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
627,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
627,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
627,3,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
627,4,Product packaging issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
627,5,Product packaging quantity issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
628,1,Dermatillomania,Obsessive-compulsive disorders and symptoms,Anxiety disorders and symptoms,Psych,N
629,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
629,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
629,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
629,4,Tachyphrenia,Thinking disturbances,Disturbances in thinking and perception,Psych,N
629,5,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
630,1,Product packaging quantity issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
630,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
631,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
632,1,Electrocardiogram PR prolongation,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
632,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
633,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
634,1,Manufacturing issue,Manufacturing issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
634,2,Prescription drug used without a prescription,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
634,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
635,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
635,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
635,3,Executive dysfunction,Cognitive and attention disorders and disturbances NEC,Cognitive and attention disorders and disturbances,Psych,N
636,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
637,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
637,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
637,3,Distractibility,Cognitive and attention disorders and disturbances NEC,Cognitive and attention disorders and disturbances,Psych,N
637,4,Drug effect less than expected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
638,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
639,1,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
639,2,Therapeutic response shortened,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
640,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
641,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
641,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
642,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
642,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
643,1,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
643,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
643,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
644,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
644,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
644,3,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
644,4,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
645,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
645,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
646,1,Dermatillomania,Obsessive-compulsive disorders and symptoms,Anxiety disorders and symptoms,Psych,N
647,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
647,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
647,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
647,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
648,1,Attention deficit hyperactivity disorder,Attention deficit and disruptive behaviour disorders,Cognitive and attention disorders and disturbances,Psych,N
648,2,Drug effect less than expected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
648,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
649,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
650,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
651,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
651,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
652,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
653,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
654,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
654,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
655,1,Prostatitis,Prostate and seminal vesicles infections and inflammations,Male reproductive tract infections and inflammations,Repro,N
656,1,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
657,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
657,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
657,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
658,1,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
659,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
659,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
659,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
660,1,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
661,1,Breast tenderness,Breast signs and symptoms,Breast disorders,Repro,N
661,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
661,3,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
662,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
663,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
664,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
664,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
664,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
664,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
664,5,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
665,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
666,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
666,2,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
667,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
667,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
667,3,Product distribution issue,Product distribution and storage issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
667,4,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
667,5,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
668,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
668,2,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
669,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
670,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
671,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
671,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
671,3,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
671,4,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
672,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
672,2,Drug tolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
673,1,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
673,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
673,3,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
673,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
673,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
673,6,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
673,7,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
674,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
674,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
675,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
676,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
676,2,Amenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
677,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
677,2,Somatic symptom disorder,Somatic symptom disorders,Somatic symptom and related disorders,Psych,N
677,3,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
678,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
678,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
678,3,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
679,1,Autism spectrum disorder,Pervasive developmental disorders NEC,Developmental disorders NEC,Psych,N
680,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
681,1,Genital discharge,Reproductive tract signs and symptoms NEC,Reproductive tract disorders NEC,Repro,N
681,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
681,3,Testicular pain,Testicular and epididymal disorders NEC,Testicular and epididymal disorders,Repro,N
682,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
683,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
683,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
683,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
684,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
684,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
685,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
685,2,Livedo reticularis,Skin vasomotor conditions,Skin vascular abnormalities,Skin,N
685,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
685,4,Oral discomfort,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
685,5,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
685,6,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
685,7,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
685,8,Telangiectasia,Telangiectasia and related conditions,Skin vascular abnormalities,Skin,N
685,9,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
686,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
686,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
686,3,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
687,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
688,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
688,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
688,3,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
688,4,Therapeutic response shortened,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
689,1,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
690,1,Stupor,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
691,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
691,2,Short-bowel syndrome,Malabsorption syndromes,Malabsorption conditions,Gastr,N
692,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
692,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
692,3,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
692,4,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
692,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
693,1,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
694,1,Migraine,Migraine headaches,Headaches,Nerv,N
695,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
695,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
695,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
696,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
697,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
698,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
698,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
699,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
700,1,Compulsive lip biting,Obsessive-compulsive disorders and symptoms,Anxiety disorders and symptoms,Psych,N
700,2,Glossitis,Tongue disorders,Tongue conditions,Gastr,N
700,3,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
700,4,Lip pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
701,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
701,2,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
702,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
702,2,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
703,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
704,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
704,2,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
705,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
706,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
706,2,Sensation of foreign body,Feelings and sensations NEC,General system disorders NEC,Genrl,N
707,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
707,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
708,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
708,2,Sensation of foreign body,Feelings and sensations NEC,General system disorders NEC,Genrl,N
709,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
709,2,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
710,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
710,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
711,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
712,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
712,2,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
713,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
713,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
714,1,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
714,2,Distractibility,Cognitive and attention disorders and disturbances NEC,Cognitive and attention disorders and disturbances,Psych,N
714,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
714,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
714,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
714,6,Product contamination,Product contamination and sterility issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
714,7,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
715,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
715,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
715,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
715,4,Headache,Headaches NEC,Headaches,Nerv,N
715,5,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
715,6,Jaw disorder,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
715,7,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
715,8,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
716,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
716,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
717,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
717,2,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
718,1,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
719,1,Cystitis interstitial,Bladder infections and inflammations,Bladder and bladder neck disorders (excl calculi),Renal,N
719,2,Irritable bowel syndrome,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
719,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
719,4,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
720,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
720,2,Inability to afford medication,Economic circumstances,Economic and housing issues,SocCi,N
720,3,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
720,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
720,5,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
720,6,Suicidal behaviour,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
721,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
722,1,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
722,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
723,1,Attention deficit hyperactivity disorder,Attention deficit and disruptive behaviour disorders,Cognitive and attention disorders and disturbances,Psych,N
723,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
723,3,Hyperthyroidism,Thyroid hyperfunction disorders,Thyroid gland disorders,Endo,N
724,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
725,1,Arteriospasm coronary,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
726,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
726,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
727,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
727,2,Blood pressure fluctuation,Blood pressure disorders NEC,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
727,3,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
727,4,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
727,5,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
727,6,Delirium,Deliria,Deliria (incl confusion),Psych,N
727,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
727,8,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
727,9,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
727,10,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
727,11,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
727,12,Muscle contractions involuntary,Neuromuscular disorders NEC,Neuromuscular disorders,Nerv,N
727,13,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
727,14,Orthostatic hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
727,15,Postural orthostatic tachycardia syndrome,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
727,16,Serotonin syndrome,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
728,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
728,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
728,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
729,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
730,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
730,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
731,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
732,1,Bruxism,Stereotypies and automatisms,Changes in physical activity,Psych,N
733,1,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
734,1,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
734,2,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
734,3,Drug effect less than expected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
734,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
734,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
735,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
735,2,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
736,1,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
736,2,Tongue injury,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
737,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
737,2,Product taste abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
738,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
739,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
739,2,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
739,3,Nephrolithiasis,Renal lithiasis,Urolithiases,Renal,N
739,4,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
739,5,Renal colic,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
739,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
739,7,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
740,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
740,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
741,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
741,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
742,1,Tic,Tic disorders,Changes in physical activity,Psych,N
743,1,Axillary mass,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
743,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
743,3,Muscle tightness,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
743,4,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
744,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
745,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
745,2,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
746,1,Migraine with aura,Migraine headaches,Headaches,Nerv,N
747,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
747,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
748,1,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
748,2,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
748,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
749,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
749,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
749,3,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
749,4,Therapeutic response shortened,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
750,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
750,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
751,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
751,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
752,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
752,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
753,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
754,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
754,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
755,1,Altered state of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
755,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
755,3,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
755,4,Communication disorder,Communications disorders,Communication disorders and disturbances,Psych,N
755,5,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
755,6,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
755,7,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
755,8,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
755,9,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
755,10,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
755,11,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
755,12,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
755,13,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
755,14,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
755,15,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
755,16,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
755,17,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
755,18,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
755,19,Therapeutic product effect variable,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
755,20,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
756,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
756,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
757,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
757,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
758,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
758,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
759,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
759,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
760,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
760,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
761,1,Allergic hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
762,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
762,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
763,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
763,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
764,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
764,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
765,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
765,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
765,3,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
765,4,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
765,5,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
765,6,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
766,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
766,2,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
766,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
767,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
767,2,Dry throat,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
767,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
767,4,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
767,5,Skin hypertrophy,Skin hyperplasias and hypertrophies,Cornification and dystrophic skin disorders,Skin,N
767,6,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
767,7,Skin tightness,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
767,8,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
767,9,Skin weeping,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
767,10,Tongue coated,Tongue signs and symptoms,Tongue conditions,Gastr,N
767,11,Tongue ulceration,Tongue disorders,Tongue conditions,Gastr,N
768,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
769,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
769,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
770,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
770,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
771,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
771,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
772,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
772,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
773,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
773,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
774,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
774,2,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
775,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
775,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
776,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
776,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
776,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
777,1,Menstruation delayed,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
778,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
778,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
779,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
779,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
779,3,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
780,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
780,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
781,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
781,2,Product dispensing error,Product dispensing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
781,3,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
781,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
782,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
782,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
783,1,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
784,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
784,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
784,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
785,1,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
785,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
786,1,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
786,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
786,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
786,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
787,1,Acne,Acnes,Skin appendage conditions,Skin,N
787,2,Dermatillomania,Obsessive-compulsive disorders and symptoms,Anxiety disorders and symptoms,Psych,N
787,3,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
787,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
788,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
788,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
788,3,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
788,4,Headache,Headaches NEC,Headaches,Nerv,N
788,5,Helplessness,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
788,6,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
788,7,Tachyphrenia,Thinking disturbances,Disturbances in thinking and perception,Psych,N
789,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
789,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
790,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
790,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
791,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
791,2,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
791,3,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
791,4,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
791,5,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
791,6,Therapeutic product effect variable,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
792,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
792,2,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
792,3,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
792,4,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
792,5,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
792,6,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
792,7,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
792,8,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
792,9,Headache,Headaches NEC,Headaches,Nerv,N
792,10,Increased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
792,11,Migraine,Migraine headaches,Headaches,Nerv,N
792,12,Mood swings,Fluctuating mood symptoms,Mood disorders and disturbances NEC,Psych,N
792,13,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
792,14,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
793,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
793,2,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
793,3,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
794,1,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
794,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
794,3,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
794,4,Screaming,General signs and symptoms NEC,General system disorders NEC,Genrl,N
795,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
795,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
796,1,Immunology test,Immunology analyses NEC,Immunology and allergy investigations,Inv,N
797,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
797,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
798,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
798,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
799,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
799,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
800,1,Product distribution issue,Product distribution and storage issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
800,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
801,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
801,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
801,3,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
801,4,Headache,Headaches NEC,Headaches,Nerv,N
801,5,Helplessness,Psychiatric symptoms NEC,Psychiatric and behavioural symptoms NEC,Psych,N
801,6,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
801,7,Tachyphrenia,Thinking disturbances,Disturbances in thinking and perception,Psych,N
802,1,Product administration interrupted,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
802,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
802,3,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
803,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
803,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
803,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
804,1,Educational problem,Educational issues,Lifestyle issues,SocCi,N
804,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
805,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
805,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
806,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
806,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
806,3,Therapeutic product effect variable,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
807,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
807,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
807,3,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
807,4,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
807,5,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
807,6,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
807,7,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
808,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
808,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
808,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
809,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
809,2,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
810,1,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
810,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
811,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
811,2,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
811,3,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
812,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
812,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
813,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
813,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
814,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
815,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
816,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
816,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
817,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
817,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
817,3,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
817,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
818,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
818,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
819,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
820,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
820,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
820,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
820,4,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
821,1,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
821,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
822,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
822,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
822,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
823,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
823,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
824,1,Loss of employment,Employment issues,Economic and housing issues,SocCi,N
824,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
824,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
824,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
824,5,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
825,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
825,2,Therapeutic product effect variable,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
826,1,Accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
826,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
826,3,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
827,1,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
827,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
827,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
827,4,Panic disorder,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
827,5,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
827,6,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
828,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
828,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
829,1,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
829,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
830,1,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
830,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
831,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
831,2,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
832,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
832,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
833,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
833,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
834,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
834,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
834,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
835,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
835,2,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
835,3,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
836,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
836,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
836,3,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
837,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
837,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
838,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
838,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
838,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
839,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
839,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
840,1,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
840,2,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
841,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
841,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
842,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
842,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
842,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
843,1,Drug effect less than expected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
843,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
843,3,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
843,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
844,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
844,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
844,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
845,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
845,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
845,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
846,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
846,2,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
847,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
847,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
848,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
848,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
848,3,Therapeutic product effect variable,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
848,4,Therapeutic response shortened,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
849,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
849,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
850,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
850,2,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
850,3,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
850,4,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
850,5,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
850,6,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
851,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
851,2,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
851,3,Impulsive behaviour,Impulse control disorders,Impulse control disorders NEC,Psych,N
851,4,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
851,5,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
851,6,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
852,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
852,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
853,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
853,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
854,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
854,2,Migraine,Migraine headaches,Headaches,Nerv,N
854,3,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
854,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
854,5,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
854,6,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
855,1,Drug withdrawal headache,Headaches NEC,Headaches,Nerv,N
855,2,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
855,3,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
856,1,Apnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
856,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
856,3,Counterfeit product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
856,4,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
856,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
856,6,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
856,7,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
856,8,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
856,9,Near death experience,Perception disturbances NEC,Disturbances in thinking and perception,Psych,N
856,10,Post-traumatic stress disorder,Stress disorders,Anxiety disorders and symptoms,Psych,N
856,11,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
856,12,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
857,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
857,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
857,3,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
857,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
858,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
858,2,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
858,3,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
859,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
859,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
860,1,Blood pressure systolic increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
860,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
860,3,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
861,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
861,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
862,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
862,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
862,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
863,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
863,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
863,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
864,1,Cerebral disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
864,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
864,3,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
864,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
864,5,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
865,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
865,2,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
866,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
867,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
867,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
868,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
868,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
868,3,Fear,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
868,4,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
868,5,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
869,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
869,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
870,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
871,1,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
871,2,Hormone level abnormal,Endocrine analyses and imaging NEC,Endocrine investigations (incl sex hormones),Inv,N
871,3,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
871,4,Menstrual disorder,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
871,5,Menstruation irregular,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
871,6,Vaginal discharge,Vulvovaginal signs and symptoms,Vulvovaginal disorders (excl infections and inflammations),Repro,N
872,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
872,2,Panic disorder,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
872,3,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
873,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
873,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
874,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
874,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
874,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
875,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
875,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
876,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
876,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
876,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
876,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
876,5,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
877,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
877,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
877,3,Panic disorder,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
877,4,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
877,5,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
878,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
878,2,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
878,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
879,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
879,2,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
879,3,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
879,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
880,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
880,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
881,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
881,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
882,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
882,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
883,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
883,2,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
884,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
884,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
884,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
885,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
885,2,Euphoric mood,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
885,3,Influenza,Influenza viral infections,Viral infectious disorders,Infec,N
885,4,Panic attack,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
885,5,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
885,6,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
885,7,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
885,8,Toothache,Dental pain and sensation disorders,Dental and gingival conditions,Gastr,N
886,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
886,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
886,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
886,4,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
887,1,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
887,2,Sexual dysfunction,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
888,1,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
889,1,Blood thyroid stimulating hormone increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
890,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
890,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
890,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
890,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
891,1,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
891,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
891,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
892,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
892,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
892,3,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
893,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
893,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
893,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
894,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
894,2,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
894,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
895,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
895,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
895,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
895,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
896,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
896,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
897,1,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
897,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
898,1,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
898,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
898,3,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
899,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
899,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
900,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
900,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
901,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
901,2,Extra dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
901,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
901,4,Manufacturing issue,Manufacturing issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
901,5,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
901,6,Product quality control issue,Manufacturing production issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
902,1,Agitated depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
902,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
902,3,Dissociative disorder,Dissociative states,Dissociative disorders,Psych,N
902,4,Foreign body sensation in eyes,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
902,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
902,6,Obsessive rumination,Obsessive-compulsive disorders and symptoms,Anxiety disorders and symptoms,Psych,N
903,1,Ileostomy,Small intestine therapeutic procedures,Gastrointestinal therapeutic procedures,Surg,N
903,2,Malabsorption,Malabsorption syndromes,Malabsorption conditions,Gastr,N
903,3,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
904,1,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
904,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
905,1,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
906,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
906,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
907,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
907,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
907,3,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
907,4,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
908,1,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
908,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
908,3,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
909,1,Attention deficit hyperactivity disorder,Attention deficit and disruptive behaviour disorders,Cognitive and attention disorders and disturbances,Psych,N
909,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
909,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
909,4,Drug withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
909,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
910,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
910,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
910,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
911,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
911,2,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
911,3,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
911,4,Therapeutic product effect variable,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
912,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
912,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
913,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
913,2,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
913,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
913,4,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
913,5,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
914,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
914,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
914,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
914,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
914,5,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
914,6,Therapeutic response shortened,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
915,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
915,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
915,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
915,4,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
915,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
915,6,Libido decreased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
915,7,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
916,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
917,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
917,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
918,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
918,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
919,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
919,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
919,3,Physical disability,Disability issues,Lifestyle issues,SocCi,N
919,4,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
920,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
920,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
920,3,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
921,1,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
921,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
921,3,Tachyphrenia,Thinking disturbances,Disturbances in thinking and perception,Psych,N
922,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
922,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
923,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
923,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
923,3,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
924,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
924,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
925,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
925,2,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
926,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
926,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
927,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
927,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
928,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
928,2,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
928,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
928,4,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
928,5,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
928,6,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
928,7,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
928,8,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
929,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
929,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
929,3,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
929,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
930,1,Yawning,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
931,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
931,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
932,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
932,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
933,1,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
934,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
934,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
935,1,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
935,2,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
936,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
936,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
936,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
937,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
937,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
937,3,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
938,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
938,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
939,1,Inability to afford medication,Economic circumstances,Economic and housing issues,SocCi,N
939,2,Post-traumatic stress disorder,Stress disorders,Anxiety disorders and symptoms,Psych,N
939,3,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
940,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
940,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
941,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
941,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
942,1,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
942,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
943,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
943,2,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
943,3,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
944,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
944,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
944,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
944,4,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
944,5,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
945,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
945,2,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
945,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
945,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
945,5,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
946,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
946,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
946,3,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
946,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
946,5,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
947,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
947,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
947,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
948,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
948,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
949,1,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
949,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
949,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
950,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
950,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
951,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
951,2,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
951,3,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
951,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
951,5,Habit cough,Somatic symptom disorders,Somatic symptom and related disorders,Psych,N
951,6,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
951,7,Oesophageal disorder,Oesophageal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
951,8,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
952,1,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
952,2,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
953,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
953,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
954,1,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
954,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
955,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
955,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
956,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
956,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
957,1,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
957,2,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
957,3,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
958,1,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
959,1,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
959,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
960,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
960,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
961,1,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
961,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
962,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
962,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
962,3,Thinking abnormal,Thinking disturbances,Disturbances in thinking and perception,Psych,N
963,1,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
963,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
964,1,Psychotic disorder,Psychotic disorder NEC,Schizophrenia and other psychotic disorders,Psych,N
965,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
965,2,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
966,1,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
967,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
967,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
967,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
968,1,Learning disability,Learning disorders,Cognitive and attention disorders and disturbances,Psych,N
968,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
968,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
968,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
969,1,Cardiac flutter,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
969,2,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
970,1,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
970,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
971,1,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
971,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
971,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
971,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
972,1,Product distribution issue,Product distribution and storage issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
972,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
973,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
973,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
973,3,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
974,1,Drug effect less than expected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
974,2,Impaired work ability,Disability issues,Lifestyle issues,SocCi,N
974,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
974,4,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
975,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
975,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
975,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
975,4,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
976,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
976,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
977,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
977,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
977,3,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
977,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
978,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
978,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
979,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
979,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
980,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
980,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
981,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
981,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
982,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
982,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
983,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
983,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
983,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
984,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
984,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
985,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
985,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
986,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
986,2,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
986,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
987,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
987,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
987,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
988,1,Drug effect less than expected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
988,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
988,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
988,4,Insurance issue,Economic circumstances,Economic and housing issues,SocCi,N
988,5,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
988,6,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
988,7,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
988,8,Therapeutic product effect increased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
989,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
989,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
989,3,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
990,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
990,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
991,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
992,1,Menstrual disorder,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
993,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
994,1,Vasoconstriction,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
995,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
995,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
996,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
996,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
996,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
997,1,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
998,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
998,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
999,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
999,2,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1000,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1001,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1001,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1002,1,Impaired quality of life,Social issues NEC,Lifestyle issues,SocCi,N
1002,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1002,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1003,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1003,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1004,1,Vasospasm,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1005,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1005,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1006,1,Drug effect less than expected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1006,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1006,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1007,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1007,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1008,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1008,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1008,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1009,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1009,2,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1010,1,Dermatillomania,Obsessive-compulsive disorders and symptoms,Anxiety disorders and symptoms,Psych,N
1011,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1011,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1011,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1011,4,Heart rate,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1011,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1011,6,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1011,7,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1012,1,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
1013,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1013,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1013,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1014,1,Haemorrhoids,Haemorrhoids and gastrointestinal varices (excl oesophageal),Gastrointestinal vascular conditions,Gastr,N
1015,1,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
1015,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1015,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1015,4,Headache,Headaches NEC,Headaches,Nerv,N
1015,5,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
1015,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1015,7,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1015,8,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1016,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1016,2,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1017,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1017,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1018,1,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1019,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1019,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1019,3,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1019,4,Therapeutic product effect variable,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1020,1,Anaesthetic complication,Anaesthetic and allied procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1020,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1021,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1021,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1021,3,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1021,4,Heavy menstrual bleeding,Menstruation with increased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
1021,5,Impatience,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1021,6,Impulsive behaviour,Impulse control disorders,Impulse control disorders NEC,Psych,N
1021,7,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1021,8,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1021,9,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1022,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1022,2,Therapeutic response shortened,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1023,1,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1023,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1023,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1024,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1024,2,Unevaluable event,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1025,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1025,2,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1025,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1026,1,Product packaging quantity issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1026,2,Product storage error,Product storage errors and issues in the product use system,Medication errors and other product use errors and issues,Inj&P,N
1026,3,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1027,1,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1028,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1028,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1028,3,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1028,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1029,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1029,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1030,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1030,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1030,3,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1031,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1031,2,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1031,3,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1031,4,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1031,5,Therapeutic response shortened,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1032,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1032,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1033,1,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1033,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1033,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1034,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1034,2,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1034,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1035,1,Gastrointestinal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1036,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1036,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1037,1,Mental disorder,Mental disorders NEC,Psychiatric disorders NEC,Psych,N
1037,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1038,1,Extra dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1038,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1038,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1038,4,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1039,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1039,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1039,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1040,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1040,2,Dysmenorrhoea,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
1040,3,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1040,4,Headache,Headaches NEC,Headaches,Nerv,N
1040,5,Intermenstrual bleeding,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
1040,6,Product packaging quantity issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1040,7,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1040,8,Product taste abnormal,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1041,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1041,2,Bradyphrenia,Thinking disturbances,Disturbances in thinking and perception,Psych,N
1041,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1041,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1041,5,Oversensing,Device malfunction events NEC,Device issues,Prod,N
1041,6,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1042,1,Blood glucose decreased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1042,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1042,3,Headache,Headaches NEC,Headaches,Nerv,N
1042,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1043,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1044,1,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1044,2,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
1044,3,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1044,4,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1045,1,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1045,2,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1046,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1046,2,Head injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
1046,3,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1047,1,Alcohol poisoning,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1048,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1048,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
1048,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1049,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1049,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1049,3,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1049,4,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1050,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1051,1,Completed suicide,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,Y
1052,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1052,2,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1052,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1052,4,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1053,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1053,2,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1053,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1054,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1054,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1054,3,Hospitalisation,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1054,4,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1055,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1055,2,Erectile dysfunction,Erection and ejaculation conditions and disorders,Sexual function and fertility disorders,Repro,N
1055,3,Initial insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1055,4,Libido increased,Sexual desire disorders,"Sexual dysfunctions, disturbances and gender identity disorders",Psych,N
1055,5,Listless,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
1055,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1056,1,Raynaud's phenomenon,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1057,1,Blood pressure diastolic increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1058,1,Initial insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1059,1,Trichorrhexis,Pilar disorders NEC,Skin appendage conditions,Skin,N
1060,1,Attention deficit hyperactivity disorder,Attention deficit and disruptive behaviour disorders,Cognitive and attention disorders and disturbances,Psych,N
1060,2,Brain fog,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1060,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1060,4,Headache,Headaches NEC,Headaches,Nerv,N
1060,5,Mental fatigue,Cognitive and attention disorders and disturbances NEC,Cognitive and attention disorders and disturbances,Psych,N
1060,6,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1061,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
1062,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1062,2,Stress at work,Employment issues,Economic and housing issues,SocCi,N
1063,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1063,2,Stress at work,Employment issues,Economic and housing issues,SocCi,N
1064,1,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
1064,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1064,3,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
1064,4,Menstruation delayed,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
1064,5,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1065,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1065,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1066,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1066,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1067,1,Mean cell volume increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1067,2,Platelet count increased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1067,3,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1068,1,Device expulsion,Device issues NEC,Device issues,Prod,N
1069,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1070,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1070,2,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
1070,3,Headache,Headaches NEC,Headaches,Nerv,N
1070,4,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
1070,5,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1070,6,Loss of personal independence in daily activities,Disability issues,Lifestyle issues,SocCi,N
1070,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1070,8,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1070,9,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1070,10,Therapeutic product effect decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1070,11,Time perception altered,Perception disturbances NEC,Disturbances in thinking and perception,Psych,N
1071,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1071,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1071,3,Therapeutic response shortened,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1072,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1072,2,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1072,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1072,4,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1072,5,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1072,6,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1072,7,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1073,1,Appetite disorder,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1073,2,Daydreaming,Cognitive and attention disorders and disturbances NEC,Cognitive and attention disorders and disturbances,Psych,N
1073,3,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1073,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1073,5,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
1073,6,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1073,7,Product availability issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1074,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1075,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1075,2,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1075,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1075,4,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
1075,5,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1075,6,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1075,7,Throat irritation,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1076,1,Hypomania,Mood alterations with manic symptoms,Manic and bipolar mood disorders and disturbances,Psych,N
1076,2,Tic,Tic disorders,Changes in physical activity,Psych,N
1077,1,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1078,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
1078,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1079,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1079,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1079,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1080,1,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
1080,2,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1080,3,Therapeutic response shortened,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1081,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1081,2,Glossodynia,Tongue signs and symptoms,Tongue conditions,Gastr,N
1081,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1081,4,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
1082,1,Heat exhaustion,Heat injuries (excl thermal burns),Injuries by physical agents,Inj&P,N
1083,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1084,1,Apathy,Mood disorders NEC,Mood disorders and disturbances NEC,Psych,N
1084,2,Appetite disorder,Appetite disorders,Appetite and general nutritional disorders,Metab,N
1084,3,Distractibility,Cognitive and attention disorders and disturbances NEC,Cognitive and attention disorders and disturbances,Psych,N
1084,4,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
1084,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1084,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1084,7,Inability to afford medication,Economic circumstances,Economic and housing issues,SocCi,N
1085,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1086,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1087,1,Impatience,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
1088,1,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1088,2,Product dose omission in error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1088,3,Product supply issue,Product supply and availability issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1089,1,Attention deficit hyperactivity disorder,Attention deficit and disruptive behaviour disorders,Cognitive and attention disorders and disturbances,Psych,N
1089,2,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
1090,1,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1091,1,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
1091,2,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1091,3,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1092,1,Chronic fatigue syndrome,Asthenic conditions,General system disorders NEC,Genrl,N
1092,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
